Reckitt Benckiser files £1bn claim against former subsidiary Indivior

by on December 19, 2020

Claim relates to US settlement over past marketing of opioid addiction treatment Suboxone (Source: FT.com – Drugs and Healthcare)

Previous post: Indivior Solutions Sentenced as Part of $2 Billion Resolution of False Safety Claims Concerning Suboxone

Next post: An alternative analysis of illicit opioid use during treatment in a randomized trial of extended-release naltrexone versus buprenorphine-naloxone: a per-protocol and completers analysis – Mitchell MM, Schwartz RP, Choo TH, Pavlicova M, O'Grady KE, Gryczynski J, Stitzer ML, Nunes EV, Rotrosen J.

Copyright 2011 Oxycontin Treatment Directory | Oxycontin Treatment Directory | All About Suboxone | About | Disclaimer | Privacy Policy Built On The Thesis Theme for WordPress

WordPress Admin

Discuss Treatment

Call 877-841-0678

X